27.08.2013 Views

Management Initiatives for the Medical Industry

Management Initiatives for the Medical Industry

Management Initiatives for the Medical Industry

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Sep 27, 2010<br />

Open Course 2010<br />

<strong>Management</strong> <strong>Initiatives</strong> <strong>for</strong> <strong>the</strong> <strong>Medical</strong> <strong>Industry</strong><br />

Presented by <strong>the</strong> University of Tokyo Global COE program “Center <strong>for</strong> <strong>Medical</strong> System Innovation (CMSI)” (Course Manager: Pharmaco-Business Innovation)<br />

[Date] October 26, 2010– March 22, 2011<br />

[Time] 18:00 – 21:00<br />

[Location] Tetsumon Memorial Hall (14 th Floor, Faculty of Medicine Experimental Research Building)<br />

Map: http://www.u-tokyo.ac.jp/campusmap/cam01_02_09_e.html<br />

[Target Audience] - Healthcare Professionals from <strong>Medical</strong> Institutes; Academic Society; Healthcare <strong>Industry</strong> including Pharmaceuticals and <strong>Medical</strong> device<br />

companies<br />

- Under- and post- graduate students (including CMSI students)<br />

- O<strong>the</strong>r professionals with a strong interest in contemporary dynamics in <strong>the</strong> medical industry<br />

[No. of Participants] 200<br />

[Course description] This course consists of a series of unique lectures by authoritative leaders from medical institutions, universities, research institutes and<br />

healthcare corporations. Each lecture focuses on recent structural dynamics in medical and healthcare systems.<br />

In June this year, <strong>the</strong> new Japanese government <strong>for</strong>mulated a new growth strategy “Blueprint <strong>for</strong> Revitalizing Japan” to revive <strong>the</strong> Japanese<br />

economy. As part of this strategic intent, medical and healthcare initiatives are expected to be key drivers <strong>for</strong> boosting t economic growth,<br />

because Japan has a “Science & Technology” advantage and "Monozukuri” which are significant foundations <strong>for</strong> developing new life-science<br />

innovation.<br />

To actualize this new growth strategy, we will examine a broad set of issues including policy, corporate management, global strategy, R&D,<br />

and innovation, as well as discussing <strong>the</strong> foundations <strong>for</strong> creating <strong>the</strong> state of <strong>the</strong> art life-science innovation.<br />

[Registration] Please write 1) your name, 2) name of your company (school), 3) telephone number and 4) e-mail address, and send by e-mail to<br />

pbi-seminar@mol.f.u-tokyo.ac.jp.<br />

[Payment <strong>for</strong> Course Registration] 50,000 yen UT Students: Free Students from o<strong>the</strong>r universities: 20,000 yen<br />

[Organization Office]<br />

Pharmaco-Business Innovation, Graduate School of Pharmaceutical Sciences, <strong>the</strong> University of Tokyo<br />

7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033 Japan<br />

Professor: Hiromichi Kimura Associate Professor: Sachiko Masuda<br />

Contact: Yoko Takahashi, Naoko Iita, Yuko Mochida<br />

Tel: +81-3-5842-2454 E-mail: pbi-seminar@mol.f.u-tokyo.ac.jp<br />

URL: http://www.f.u-tokyo.ac.jp/~pbi/index.htm<br />

1


Schedule might be changed on <strong>the</strong> basis of lecturers’ schedule<br />

Date Lecture Title Speaker Affiliation Title<br />

1 Oct.26th (Tue.)<br />

Introduction<br />

New Growth<br />

Strategy<br />

Hiromichi Kimura<br />

Yosuke Kondo<br />

Graduate School of<br />

Pharmaceutical Sciences<br />

The University of Tokyo<br />

Member of <strong>the</strong> House of<br />

Representatives<br />

Professor<br />

The <strong>for</strong>mer Vice Minister of Economy, Trade and <strong>Industry</strong><br />

2 Nov.9th (Tue.)<br />

3 Nov.24th (Wed.)<br />

4 Dec.7th (Tue.)<br />

5 Dec.21st (Tue.)<br />

6 Jan.11th (Tue.)<br />

7 Jan.25th (Tue.)<br />

The Front Lines of<br />

Cancer Treatment<br />

National Security<br />

(Infectious disease)<br />

Global Life Science<br />

Innovation<br />

Strategy <strong>for</strong> new<br />

drug<br />

Challenge <strong>for</strong><br />

Innovative Medicine<br />

Med-term View of<br />

Pharmaceutical<br />

Companies<br />

8 Feb.8th (Tue.) <strong>Medical</strong> Devices<br />

9 Mar.1st (Tue.) Cluster<br />

10 Mar.22nd (Tue.) Innovation<br />

Tetsuichiro Muto<br />

Hiroyasu Esumi<br />

Masato Iwasaki<br />

JAPANESE FOUNDATION<br />

FOR CANCER RESEARCH<br />

National Cancer Center<br />

Hospital East<br />

Takeda Pharmaceutical<br />

Company Ltd.<br />

Executive Director, <strong>Medical</strong> Director,<br />

The <strong>for</strong>mer Director<br />

Corporate Officer, Senior Vice President, Strategic Product<br />

Planning Department<br />

Shigeru Omi Jichi <strong>Medical</strong> University Professor, Public Health, Center <strong>for</strong> Community Medicine<br />

Bruce Howard U.S. Embassy in Japan<br />

Unit Chief, Environment, Science, Technology and Health<br />

Unit, Economic Section<br />

Chris Pook British Embassy Tokyo Counsellor, Science & Innovation Section<br />

Hideo Utsumi<br />

Pharmaceutical and <strong>Medical</strong><br />

Devices Agency<br />

Executive Director<br />

Director, Center <strong>for</strong> Product Evaluation<br />

Ichiro Umeda Pfizer Japan Inc. President & Chief Executive Officer<br />

Kentaro Yoshimatsu Eisai Co., Ltd. Senior Vice President, Chief Scientific Officer<br />

Tohru Yasukohchi NOF CORPORATION<br />

Tony Alvarez<br />

Banyu Pharmaceutical<br />

Co., Ltd.<br />

Ken Yamazumi Kyowa Hakko Kirin Co., Ltd.<br />

Kazuhisa Yanagisawa Olympus Corporation<br />

David W. Powell<br />

Johnson & Johnson K.K.<br />

<strong>Medical</strong> Company<br />

Takashi Miki City of KOBE<br />

Toshio Kuroki<br />

Gifu Research and<br />

Development Foundation<br />

Nobuhide Kobayashi Kawasaki City Office<br />

Koichi Kitazawa<br />

(TBD)<br />

Japan Science and Technology<br />

Agency<br />

General Manager, DDS Research Laboratory,<br />

DDS Development Division<br />

Representative Director and President<br />

Executive Director of <strong>the</strong> Board<br />

Executive Vice President<br />

Director, Member of <strong>the</strong> Board, Senior Executive Managing<br />

Officer, Group President, Corporate R&D Center<br />

President<br />

Director General, <strong>Medical</strong> <strong>Industry</strong> Development Project<br />

Planning and Coordination Bureau, City of KOBE<br />

Chief Director (Robotics Advanced <strong>Medical</strong> Cluster)<br />

Director , Kanagawa Gateway and Coastal Area<br />

Development Office,<br />

General Planning Bureau<br />

President<br />

2

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!